We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Global ELISA Analyzers Market Driven by Demand for Technologically Advanced Immunological Tools

By LabMedica International staff writers
Posted on 30 Oct 2023
Print article
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)

Enzyme-Linked Immunosorbent Assay, commonly known as ELISA, is a laboratory test used for detecting antibodies in the blood. ELISA tests operate on the interaction between antibodies and antigens, making it useful for diagnosing diseases. Automated instruments, or analyzers, carry out various steps of the test, ensuring both accuracy and consistent results. As the incidence of diseases like cancer, hepatitis, and HIV rises globally, there is a growing need for diagnostic tools like ELISA, thereby boosting the market for ELISA analyzers. The global ELISA analyzers market is projected to grow at an impressive rate from 2024 to 2028, due to the increasing demand for reliable infectious disease tests and the growing need for technologically advanced diagnostic tools.

These are the latest findings of Research and Markets (Ireland, UK), a provider of market research reports.

Analyzers are engineered to meet specific requirements for running immunological tests, such as maintaining test sensitivity, reducing background noise, and ensuring quick and consistent outcomes. Some modern ELISA analyzers, like open-system automated analyzers, come with pre-set testing options and easy-to-follow guides, simplifying the setup process and making it more convenient for users. Innovations in automation, like increased walkaway time and throughput, are also minimizing the labor-intensive aspects of handling large samples, which is anticipated to further drive market growth in the coming years.

In addition, their ability to measure enzyme activity and detect soluble proteins and cytokines is also increasing the demand for ELISA analyzers. The rise in allergy cases is spurring a need for diagnostic techniques, including ELISA, which is frequently employed for identifying food allergies. The indirect IgE-ELISA method is commonly used for detecting specific allergen-related IgE in blood serum due to its cost-effectiveness and simplicity compared to other systems. ELISA also has applications in measuring antibody levels used for assessing vaccine effectiveness, resulting in growing demand from companies that are at the forefront of vaccine development.

Related Links:
Research and Markets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.